Development Level

Tbio 19 | 10,625
Tchem 14 | 1,890
Tdark 5 | 7,003
Tclin 1 | 602

IMPC Term

preweaning lethality, complete... 2 | 633
abnormal behavior 1 | 226
abnormal bone structure 1 | 131
abnormal cervical vertebrae mo... 1 | 4
abnormal digit morphology 1 | 13
abnormal rib morphology 1 | 28
abnormal thoracic vertebrae mo... 1 | 16
decreased body length 1 | 108
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 49
decreased circulating HDL chol... 1 | 77
decreased circulating LDL chol... 1 | 37
decreased circulating alanine ... 1 | 53
decreased circulating choleste... 1 | 85
decreased circulating creatini... 1 | 31
decreased circulating fructosa... 1 | 31
decreased erythrocyte cell num... 1 | 43
decreased fasted circulating g... 1 | 49
decreased lean body mass 1 | 195
decreased rib number 1 | 59
decreased total body fat amoun... 1 | 186
hypoactivity 1 | 89
impaired righting response 1 | 19
improved glucose tolerance 1 | 56
increased body weight 1 | 42
increased circulating alkaline... 1 | 119
increased circulating amylase ... 1 | 13
increased grip strength 1 | 83
increased mean corpuscular hem... 1 | 93
increased mean corpuscular vol... 1 | 91
rib fusion 1 | 2
short tibia 1 | 82
vertebral fusion 1 | 23

Disease

ovarian cancer 16 | 8,492
osteosarcoma 14 | 7,933
intraductal papillary-mucinous adenoma (IPMA) 12 | 2,956
psoriasis 12 | 6,685
glioblastoma 11 | 5,572
lung cancer 11 | 4,473
malignant mesothelioma 11 | 3,163
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,289
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,988
pituitary cancer 9 | 1,972
medulloblastoma, large-cell 8 | 6,234
non-small cell lung cancer 8 | 2,798
pancreatic ductal adenocarcinoma liver metastasis 8 | 1,795
Breast cancer 7 | 3,099
Cancer 7 | 2,346
lung adenocarcinoma 7 | 2,714
pancreatic cancer 7 | 2,300
Cholestasis 6 | 93
adrenocortical carcinoma 6 | 1,427
atypical teratoid / rhabdoid tumor 6 | 4,369
cystic fibrosis 6 | 1,670
lung carcinoma 6 | 2,844
Bilirubin metabolic disorder 5 | 39
Obesity 5 | 616
Rheumatoid Arthritis 5 | 1,171
colon cancer 5 | 1,475
primitive neuroectodermal tumor 5 | 3,031
Carcinoma 4 | 2,147
Hypothyroidism 4 | 89
active Crohn's disease 4 | 918
active ulcerative colitis 4 | 477
diabetes mellitus 4 | 1,663
interstitial cystitis 4 | 2,299
invasive ductal carcinoma 4 | 2,950
medulloblastoma 4 | 1,524
pilocytic astrocytoma 4 | 3,086
posterior fossa group A ependymoma 4 | 1,511
subependymal giant cell astrocytoma 4 | 2,287
Adverse reaction to drug 3 | 54
Congenital disorder of glycosylation 3 | 53
Epilepsy 3 | 346
Liver disease 3 | 219
Neonatal jaundice 3 | 15
Otitis media 3 | 32
Pick disease 3 | 1,893
Pneumonia 3 | 133
breast carcinoma 3 | 1,614
cutaneous lupus erythematosus 3 | 1,056
ductal carcinoma in situ 3 | 1,745
group 3 medulloblastoma 3 | 2,254
nephrosclerosis 3 | 329
pediatric high grade glioma 3 | 2,712
posterior fossa group B ependymoma 3 | 1,530
Acute kidney injury 2 | 65
Alcohol dependence 2 | 107
Allan-Herndon-Dudley syndrome 2 | 11
Alzheimer's disease 2 | 644
Attention deficit hyperactivity disorder 2 | 156
Brain disease 2 | 84
Bronchitis 2 | 44
Cerebrovascular disease 2 | 231
Diarrhea 2 | 155
Heart failure 2 | 80
Hyperbilirubinemia, Rotor type 2 | 2
Hypercalcemia 2 | 37
Hypertension 2 | 293
Hypertensive disease 2 | 193
Hyperuricemia 2 | 35
Hypoglycemia 2 | 81
Hypotension 2 | 53
Intellectual disability 2 | 573
Keratoconjunctivitis sicca 2 | 19
Kidney disease 2 | 397
Liver Cirrhosis 2 | 101
Mammary Neoplasms 2 | 410
Meningitis 2 | 46
Myopathy 2 | 128
Pain 2 | 70
Paraplegia 2 | 71
Peripheral Neuropathy 2 | 303
Portal hypertension 2 | 21
Prevention of Cardiac Transplant Rejection 2 | 14
Prevention of Kidney Transplant Rejection 2 | 16
Prevention of Liver Transplant Rejection 2 | 14
Rotor Syndrome 2 | 2
Severe Recalcitrant Psoriasis 2 | 11
Tear film insufficiency 2 | 14
Tetanus 2 | 66
Thyrotoxicosis 2 | 38
acute quadriplegic myopathy 2 | 1,157
adult high grade glioma 2 | 2,148
atypical teratoid/rhabdoid tumor 2 | 1,095
hearing impairment 2 | 40
nasopharyngeal carcinoma 2 | 1,056
primary pancreatic ductal adenocarcinoma 2 | 1,271
progressive supranuclear palsy 2 | 674
sonic hedgehog group medulloblastoma 2 | 1,482
spina bifida 2 | 1,064
tuberculosis 2 | 1,563
ulcerative colitis 2 | 2,087

Tissue

Digestive Tract 39 | 18,473
Endocrine System 39 | 18,512
Female tissues 39 | 18,647
Liver and Pancreas 39 | 18,136
Nervous System 39 | 18,561
Urinary Tract 39 | 18,444
Blood and immune system 38 | 17,995
Male tissues 38 | 17,969
Skin and soft tissues 38 | 18,115
Cardiovascular System 37 | 17,958
Respiratory system 37 | 17,484

Target Family

Transporter 31 | 473
Non-IDG 8 | 11,969

Reactome Pathway

Transport of vitamins, nucleos... 39 | 39
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Equilibrative nucleoside transporter 1 SLC29A1 Tclin Transporter -2.59024 397.3 363
Solute carrier organic anion transporter family member 3A1 SLCO3A1 Tbio Transporter -1.38328 23.0 28
Long-chain fatty acid transport protein 6 SLC27A6 Tbio Transporter -1.68560 46.7 49
Long-chain fatty acid transport protein 4 SLC27A4 Tchem Transporter -1.75479 57.3 71
Vasopressin-neurophysin 2-copeptin AVP Tbio Non-IDG -3.91847 8071.2 168
Solute carrier organic anion transporter family member 1B1 SLCO1B1 Tchem Transporter -2.74527 533.5 99
Epididymal-specific lipocalin-9 LCN9 Tdark Non-IDG -0.47470 2.72 53
Monocarboxylate transporter 8 SLC16A2 Tbio Transporter -2.34494 230.6 103
Equilibrative nucleoside transporter 3 SLC29A3 Tbio Transporter -2.39437 247.3 58
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter SLC35D2 Tdark Transporter -1.57612 37.7 44